Coronavirus dashboard for October 20: some good news among the gloom ; Total US confirmed infections: 8,273,296* Average US infections last 7 days: 59,527 (vs. recent low of 34,354 on Sept 12) Total US deaths: 221,052 Average US deaths last 7 days: 738 (vs. recent low of 689 4 days ago) *I suspect the real […] [Read More...]
COVID-19, Moderna Therapeutics mRNA Vaccine, and Crichton
I understood how some combinations of drugs work in attacking Covid-19 with one drug acting as an ionophore allowing another drug to enter a cell and attach to Covid RNA stopping its replication. I found this nice chart on National Geographic offering up an educational semi -medical and microbiologist depiction of how Moderna’s new vaccine […] [Read More...]
Pandemic boundaries
Via the Boston Globe comes the consideration of boundary problems this pandemic poses between US states. Worth a discussion. Also, on the world stage, the EU and other countries consider relaxing travel restrictions from ‘safe’ countries, the US not among them. Visitor quarantines may seem like a smart intervention to keep the virus from crossing […] [Read More...]
Coronavirus dashboard for June 12: the costs of recklessly reopening begin to come due
Coronavirus dashboard for June 12: the costs of recklessly reopening begin to come due – by New Deal democrat It is pretty clear now that in general those States (but not all) which left lockdowns the earliest and with the most lax continuing restrictions are suffering renewed outbreaks of the coronavirus, *possibly* in several cases […] [Read More...]
Will Labor and Capitalism Survive the Current Republican Party?
On April 20th Georgia Governor Kemp called for “reopening more of the state’s economy to minimize the ‘terrible impact of Covid-19 on public health and the pocketbook.’” It would apply to certain non-essential businesses. Kemp, who was later told by Trump it was too early to reopen Georgia’s economy, was following Trump’s lead to begin […] [Read More...]
Coronavirus dashboard for April 4: with lockdowns in place, testing still far behind, no action on necessary “test, track, quarantine” plan
Coronavirus dashboard for April 4: with lockdowns in place, testing still far behind, no action on necessary “test, track, quarantine” plan – by New Deal democrat Here is the update through yesterday (April 3) I’ve changed the format, moving the “just the facts, ma’am” data to the top, and comments at the end. The four […] [Read More...]
Hydroxychloroquine, Anthony Fauci and Kevin Drum
This is a comment on “Is Anthony Fauci Really Our Truthteller-in-Chief?” by Kevin Drum. I will briefly summarize. Drum quotes from the latest press conference “Is there any evidence to suggest that, as with malaria, it might be used as a prophylaxis against COVID-19? DR. FAUCI: No. The answer is no.” Later after Trump says […] [Read More...]
Science Backed Home Healthcare Remedies
From treehuggers, “Home Remedies,” Melissa Breyer, August 12, 2019 treehugger publication was also a part of Slate’s “Green Challenge” which Slate started publishing in conjunction with treehugger.org. a decade plus few years or so ago. Chicken Soup for a Cold? Toronto-based dietitian and Director of Food and Nutrition at Medcan, Leslie Beck: “There is no […] [Read More...]
Technology and Productivity. What went wrong?
Kevin Drum wrote a typically brilliant post on absurdly high estimates of the growth of the number of health care administrators. I was very interested in one little passage. My comment. Dear Kevin You used to work for a tech company and IIRC in public relations. Now your day job is as a blogger-journalist. Don’t […] [Read More...]
Seema Verma Spends $Millions of Taxpayer Funds Trying to Improve Her Reputation
Spoiler: It isn’t working. Charles Gaba at ACA Signups had this up. In an excellent scoop by Dan Diamond and Adam Cancryn this morning, Politico reports that CMS Administrator Seema Verma, the woman in charge of Medicare and Medicaid who takes great joy in trashing Medicare and Medicaid has spent millions of dollars on partisan […] [Read More...]
CVS – Earnings Implosion And Opaque Near-Term
The pharmaceutical supply chain cohort is simply unable to obtain firm footing in the backdrop consolidation within the sector, legislative backdrop, drug pricing pressures, rising insurance costs and a market that has lost patience with these stocks. All of these factors culminate into sub-par growth with a level of uncertainty as this sector continues to […] The post CVS – Earnings Implosion And Opaque Near-Term appeared first on INO.com Trader's Blog. [Read More...]
Why Your Next Startup Should Focus on Healthcare
Breakdowns exist in the healthcare system, specifically in the efficiency and accuracy of patient care. But that provides enterprising entrepreneurs with opportunities to fill those gaps through tech. [Read More...]
The Ethics of Clinical Trials
In a clinical trial the therapy is decided by a pseudo random number generator. How can this be ethical ? People are treated differently for no reason related to different interests different values and priorities or even different merit (assuming merit can differ). There is a utilitarian rational for clinical trials. Through such trials doctors […] [Read More...]
Johnson & Johnson Stock Not Discounted Much After Renewed Talc Media Blitz
Shares of healthcare giant Johnson and Johnson (JNJ) have come under pressure in recent days as media reports have once again resurface, suggesting that the company has potentially hid evidence that trace amounts of asbestos have been found in the talc powder products over multiple decades. Whenever news like this hits, especially with large dominant franchises with plenty of free cash flow to cover possible legal verdicts (think BP earlier this decade), it pays to see if investors are getting a short-term bargain, enough to compensate them for what is likely to be plenty of headline risk over the coming weeks and months. With JNJ shares only down about 15% from their highs (not much more than the S&P 500 index), no such bargain seems to … [Read More...]